Prostate cancer markers explained

A marker is a measurable substance associated with a body process. In prostate care, PSA is the main blood marker. Prostate cells can release PSA whether they are healthy, enlarged, inflamed, or cancerous, so the result needs context. Doctors may compare repeated results, examine the prostate, review urinary symptoms, and use scans or biopsy when appropriate.

A marker may be used before diagnosis, after treatment, or during ongoing monitoring. The meaning of a change depends on the treatment received, the time since treatment, and the pattern across tests. One number should not be treated as a diagnosis or a complete picture.

Ask for the exact marker, the laboratory result, and the plan for interpreting it. Mention infection, recent ejaculation, catheterisation, prostate examination, procedures, and medicines because these details can affect assessment. Difficulty passing urine deserves its own clinical review; a symptom does not establish that cancer is present.

Keep results together so your clinician can see the trend. If further testing is advised, ask what question it is intended to answer and how the result could alter treatment. Options may include observation, imaging, biopsy, radiotherapy, surgery, or medicines, depending on the full assessment.

Seek prompt care for inability to pass urine, fever with urinary symptoms, persistent visible blood in urine, or new severe pain. Emergency assessment is needed for sudden leg weakness, loss of bladder or bowel control, collapse, or severe breathing difficulty.

What does this marker measure? How does my result compare with earlier results? Could another condition explain the change? Which test would clarify the situation, and when should the marker be checked again?